| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/21/1997 | EP0474790B1 Media for cell growth and method for making them |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5631159 Cell viability or recombitant proteins,alcohol hydrolysis product of phosphoglycerides esters for releasing esters |
| 05/20/1997 | US5631137 Reaction-based selection for expression of and concentration of catalytic moieties |
| 05/20/1997 | US5631006 Cells for culture and leukocytes |
| 05/15/1997 | WO1997017458A1 Accessory functions for use in recombinant aav virion production |
| 05/15/1997 | WO1997017457A2 Stable packaging cell line producing pseudotyped retroviruses |
| 05/15/1997 | WO1997017447A2 Plant vde genes and methods related thereto |
| 05/15/1997 | WO1997017443A1 Huntingtin-associated protein |
| 05/15/1997 | WO1997017440A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | WO1997017433A1 Tissue-specific and target rna-specific ribozymes |
| 05/15/1997 | WO1997017432A1 Insecticidal protein toxins from photorhabdus |
| 05/15/1997 | WO1997017430A1 Reconstituted mineralized cartilage tissue |
| 05/15/1997 | WO1997017429A1 Method for the commercial production of transgenic plants |
| 05/15/1997 | WO1997017038A1 Tissue re-surfacing with hydrogel-cell compositions |
| 05/15/1997 | WO1997010328A3 Compositions and method for modulation of gene expression in plants |
| 05/15/1997 | WO1997006259A3 Resistance against wilt inducing fungi |
| 05/15/1997 | WO1997004113A3 Inhibition of gene expression |
| 05/15/1997 | WO1997003635A3 P16 expression constructs and their application in cancer therapy |
| 05/15/1997 | DE19541345A1 Culturing eucaryotic cells in medium containing serum or serum substitute |
| 05/15/1997 | CA2237000A1 Stable packaging cell line producing pseudotyped retroviruses |
| 05/15/1997 | CA2236807A1 Reconstituted mineralized cartilage tissue |
| 05/15/1997 | CA2236267A1 Plant vde genes and methods related thereto |
| 05/15/1997 | CA2235631A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | CA2235347A1 In vitro construction of sv40 viruses and pseudoviruses |
| 05/14/1997 | EP0773294A2 Efficient directional genetic cloning system |
| 05/14/1997 | EP0773293A2 Genetically engineered tumour cell lines and their use in the screening of antitumour-compositions |
| 05/14/1997 | EP0773292A1 Immortalised embryonic hippocampal cells and their use |
| 05/14/1997 | EP0773290A2 Novel LDL receptor analog protein and the gene coding therefor |
| 05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
| 05/14/1997 | EP0773287A1 Immortalised embryonic hyppocampal cells and their use |
| 05/14/1997 | EP0772972A1 Cell preservative solution |
| 05/14/1997 | EP0772773A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 05/14/1997 | EP0772690A1 Recombinant virus vectors |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772685A1 Heat-stable prolylendopeptidase |
| 05/14/1997 | EP0772683A1 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 05/14/1997 | EP0772678A1 Modulation of drug radiation resistant genes |
| 05/14/1997 | EP0772677A1 T cell activation |
| 05/14/1997 | EP0772676A1 Method of control of microorganism growth process |
| 05/14/1997 | EP0772634A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 05/14/1997 | EP0772632A2 T cell stimulating protein of pestivirus |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772624A1 Interleukin-15 |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772425A1 Membrane for regenerating body tissues and use of said membrane as a wound covering and substitute skin |
| 05/14/1997 | EP0772404A1 Production of collagen in the milk of transgenic mammals |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | EP0615453B1 Anti-cancer immunotherapeutic vector constructs |
| 05/14/1997 | EP0494216B1 Surfaces having desirable cell adhesive effects |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
| 05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629194 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629191 Method of making a porous matrix particle |
| 05/13/1997 | US5629186 Porous matrix and method of its production |
| 05/13/1997 | US5629175 Molecular farming |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5629159 Immortalization and disimmortalization of cells |
| 05/13/1997 | US5628781 Having a specified surface porosity and permeability |
| 05/09/1997 | WO1997016732A1 A process for in vitro analysis of toxic and allergenic substances |
| 05/09/1997 | WO1997016559A1 Plants with reduced glucosinolate content |
| 05/09/1997 | WO1997016554A1 Modified plants and plant products |
| 05/09/1997 | WO1997016552A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016546A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | WO1997016545A1 Neuronal stimulation using electrically conducting polymers |
| 05/09/1997 | WO1997016539A1 Recombinant sendai virus |
| 05/09/1997 | WO1997016538A1 (-)-strand rna virus vector having autonomously replicating activity |
| 05/09/1997 | WO1997016537A1 Stable chicken b-cell line and method of use thereof |
| 05/09/1997 | WO1997016536A1 Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016534A1 Normal neural epithelial precursor cells |
| 05/09/1997 | WO1997016458A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016176A1 Angiogenic material and uses thereof |
| 05/09/1997 | WO1997016064A1 Methods and compositions for the reduction of xenotransplantation rejection |
| 05/09/1997 | WO1997004089A3 Porphyrin-accumulating type herbicide resistance gene |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | CA2236749A1 Neuronal stimulation using electrically conducting polymers |
| 05/09/1997 | CA2236474A1 A process for in vitro analysis of toxic and allergenic substances |
| 05/09/1997 | CA2236448A1 Molecular cloning by multimerization of plasmids |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236274A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | CA2235623A1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 05/09/1997 | CA2235619A1 Modified plants and plant products |
| 05/09/1997 | CA2234230A1 Normal neural epithelial precursor cells |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |